Net Cash Provided by (Used in) Operating Activities |
143M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-969M |
USD |
-186% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
477M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
4K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
3K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
25K |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.21B |
USD |
+36.5% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
34M |
USD |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
3.63B |
USD |
+9.15% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.72B |
USD |
|
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
2B |
USD |
+9.69% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
2M |
USD |
-85.7% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
17.6B |
USD |
+0.57% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
3.63B |
USD |
+9.15% |
Q4 2024 |
FY 2024 |